Parallel Advisors’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.3K Sell
3,909
-747
-16% -$2.83K ﹤0.01% 2613
2025
Q4
$13.7K Buy
4,656
+2,077
+81% +$5.69K ﹤0.01% 2481
2025
Q3
$6.24K Buy
2,579
+635
+33% +$2.04K ﹤0.01% 2698
2025
Q2
$6.38K Buy
1,944
+20
+1% +$72 ﹤0.01% 2653
2025
Q1
$7.41K Buy
+1,924
New +$7.99K ﹤0.01% 2549
2019
Q3
Sell
-629
Closed -$12K 2395
2019
Q2
$12K Buy
629
+535
+569% +$12.9K ﹤0.01% 1494
2019
Q1
$2K Hold
94
﹤0.01% 2054
2018
Q4
$2K Hold
94
﹤0.01% 1843
2018
Q3
$3K Hold
94
﹤0.01% 1870
2018
Q2
$2K Hold
94
﹤0.01% 1814
2018
Q1
$3K Hold
94
﹤0.01% 1691
2017
Q4
$2K Hold
94
﹤0.01% 1822
2017
Q3
$3K Hold
94
﹤0.01% 1727
2017
Q2
$2K Buy
+94
New +$1.94K ﹤0.01% 1846

Other funds holding BAK

Parallel Advisors's BAK Position: Q1 2026 in Review

Parallel Advisors reduced its Braskem (BAK) stake by 16% in Q1 2026, selling an estimated $2.83K and leaving 3,909 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2613.

Parallel Advisors first reported a position in BAK in Q2 2017 and has held it in 14 quarters since. 64 funds tracked by Wall St. Rank hold BAK as of Q1 2026.

  • Parallel Advisors held 3,909 shares of Braskem worth $14.3K as of Q1 2026.
  • Parallel Advisors sold 747 Braskem shares in Q1 2026, an estimated $2.83K.
  • Braskem made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #2613 holding.
  • Parallel Advisors first reported a position in Braskem in Q2 2017 and has held it in 14 quarters since.
  • 64 funds tracked by Wall St. Rank held Braskem as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.